---
document_datetime: 2025-06-24 13:21:57
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/siiltibcy-epar-all-authorised-presentations_en.pdf
document_name: siiltibcy-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8721577
conversion_datetime: 2025-12-30 10:49:33.286132
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength              | Pharmaceutical Form    | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size                                           |
|------------------|-------------------|-----------------------|------------------------|---------------------------|-----------------------|---------------------------|-----------------------------------------------------|
| EU/1/24/1882/001 | SIILTIBCY         | 0.5 µg/ml / 0.5 µg/ml | Solution for injection | Intradermal use           | vial (glass)          | 1 ml (10 doses)           | 1 multidose vial (10 doses)                         |
| EU/1/24/1882/002 | SIILTIBCY         | 0.5 µg/ml / 0.5 µg/ml | Solution for injection | Intradermal use           | vial (glass)          | 1 ml (10 doses)           | 10 (10 x 1) multidose vials (multipack) (100 doses) |